Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for prevention of contrast-induced nephropathy in diabetic patients undergoing angioplasty
IRCT201603038307N14Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pentoxifylline in contrast-induced nephropathy (CIN), sponsored by Tabriz University of Medical Sciences. Started Jun 2016; status: completed.
02
Drugs
pentoxifylline
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on IRCT201603038307N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201603038307N14.